“When a woman becomes pregnant, naturally, she wants to protect her unborn child above all else. Therefore, when offered a series of vaccinations said to protect her newborn baby against disease in the first few weeks of life, she will probably accept the vaccinations without a moment’s hesitation.
But would she accept those vaccinations so readily if she knew that their effects on unborn children had not been tested, but rather, the Centers for Disease Control and Prevention (CDC) and the vaccine manufacturers had been taking a ‘wait and see’ approach based on injury and fatality reports?
Both the Tdap and the Dtap are vaccinations offered to pregnant women during pregnancy, supposedly to protect their newborn infant from contracting pertussis (whooping cough) in the first few weeks of life.
However, despite recommending these vaccinations to all pregnant women, the CDC readily admits in their own documentation that neither vaccine has ever been tested during pregnancy for vaccine safety and that, even today, they have no idea whether the vaccines can harm a growing fetus. How was―and is―this policy possible?
In 2008, the CDC stated the following in a report titled Prevention of Pertussis, Tetanus, and Diphtheria Among Pregnant and Postpartum Women and Their Infants – Recommendations of the Advisory Committee on Immunization Practices (ACIP):
‘Available evidence does not address the safety of Tdap for pregnant women, their fetuses, or pregnancy outcomes sufficiently. Available data also do not indicate whether Tdap-induced transplacental maternal antibodies provide early protection against pertussis to infants or interfere with an infant’s immune responses to routinely administered pediatric vaccines.’
‘The safety and efficacy of using Tdap in pregnant women has not been demonstrated, and Tdap is not recommended for use in pregnant women in any country. No evidence exists of excess morbidity or any fatality among pregnant women ascribed to pertussis. No evidence exists demonstrating whether:
– Tdap in pregnant women harms the fetus or increases risk for adverse pregnancy outcomes,
– transplacental antibody induced by Tdap administered during pregnancy will protect infants against pertussis, or
– Tdap-induced transplacental maternal antibody will have a negative impact on an infant’s protective immune response to later-administered routine pediatric DTaP or to conjugate vaccines containing tetanus toxoid or diphtheria toxoid.’
However, three years later, in 2011, based on no further research, the Tdap, an untested, non-recommended vaccine was recommended by the CDC as, not only safe, but necessary and offered to all pregnant women to protect their newborn babies from whooping cough.
So, not only did the CDC conduct no further testing, but the vaccine manufacturers themselves could not provide any evidence to suggest that this vaccine is either safe or effective.”
― Claire Dwoskin, Dwoskin Family Foundation